Arkolith/Insider Trading/AADI/Form 4

Giacobello Scott M.

CHIEF FINANCIAL OFFICERAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Mar 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2024Grant(A)138K—$0138K
Mar 1, 2024Grant(A)27K—$027K
Mar 1, 2024Grant(A)55K—$055K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-006411) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML